Here's Why bluebird bio's Shares Soared 24% in November
After bluebird bio (NASDAQ: BLUE) updated investors on the presentations it will be making at a key industry conference soon, its shares jumped 24.2% in November, according to S&P Global Market Intelligence.
The company is on the cutting edge of gene-therapy research, and in November, management unveiled data that it will be presenting this month at the high-profile American Society of Hematology conference, which runs from December 9 to December 12.
IMAGE SOURCE: GETTY IMAGES.
Source: Fool.com
Bluebird Bio Inc. Stock
€0.84
1.430%
Our community is currently low on Bluebird Bio Inc. with 4 Buy predictions and 6 Sell predictions.
On the other hand, the target price of 8 € is above the current price of 0.84 € for Bluebird Bio Inc., so the potential is actually 853.06%.
